News
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
Bristol Myers’ (BMY) CAR T cell therapy Breyanzi (lisocabtagene maraleucel; liso-cel) posted strong growth in the second quarter.
Breyanzi is a CD19-directed CAR T cell therapy with a 4-1BB
Gauzy Ltd. (GAUZ) Reports Q2 Loss, Lags Revenue Estimates
Gauzy Ltd. (GAUZ) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.88 per share a year ago. These figures are
Zacks Industry Outlook Highlights Globant and NetEase
Is the Options Market Predicting a Spike in Canadian Pacific Stock?
Investors in Canadian Pacific Kansas City Limited CP need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 19, 2025 $50 Call had some of the
Zacks Industry Outlook Highlights Broadcom and Applied Materials
If You Invested $1000 in Aecom Technology a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
Alithya Group (ALYAF) Beats Q1 Earnings Estimates
Alithya Group (ALYAF) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.04 per share a year ago. These
If You Invested $1000 in Tractor Supply a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
Here's How Much a $1000 Investment in BlackRock Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
Sapiens (SPNS) Surpasses Q2 Earnings and Revenue Estimates
Sapiens (SPNS) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.37 per share a year ago. These figures
Lowe's Q2 2025 Earnings Preview: Is LOW Ready to Surprise the Street?
As Lowe's Companies, Inc. LOW prepares to unveil its second-quarter fiscal 2025 earnings on Aug. 20, before the opening bell, investors are eager to see if the company can beat market expectations
Implied Volatility Surging for Baldwin Insurance Stock Options
Investors in The Baldwin Insurance Group, Inc. BWIN need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 19, 2025 $20 Call had some of the
Local Bounti Corporation (LOCL) Reports Q2 Loss, Misses Revenue Estimates
Local Bounti Corporation (LOCL) came out with a quarterly loss of $1.63 per share versus the Zacks Consensus Estimate of a loss of $1.95. This compares to a loss of $3 per share a year ago. These
Sanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue Estimates
Sanara MedTech Inc. (SMTI) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.41 per share a year ago. These
Arcos Dorados (ARCO) Tops Q2 Earnings and Revenue Estimates
Arcos Dorados (ARCO) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.13 per share a year ago. These
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength
Hologic HOLX completed its annual strategic planning process earlier this year and expects to get back to solid mid-single-digit organic revenue growth next year and beyond. A major driver of this
The Zacks Analyst Blog Highlights Bank of America, Roche, Intuit and TSS
For Immediate Release
Chicago, IL – August 13, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
Globus Medical, Inc. GMED reported second-quarter 2025 adjusted earnings per share (EPS) of 86 cents, which surpassed the Zacks Consensus Estimate by 13.16%. The figure increased 14.1% year over
Kamada (KMDA) Q2 Earnings Top Estimates
Kamada (KMDA) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago. These figures are
Marex Group PLC (MRX) Tops Q2 Earnings and Revenue Estimates
Marex Group PLC (MRX) came out with quarterly earnings of $1.02 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.9 per share a year ago. These
MRCY Stock Surges 27% as Q4 Earnings and Revenue Beat Estimates
Mercury Systems MRCY shares jumped nearly 27% as the company's results for the fourth quarter of fiscal 2025 surpassed analyst expectations and improved year over year.MRCY reported fourth-quarter
The Zacks Analyst Blog Highlights Pan American Silver, Carlisle Companies and DHT
For Immediate Release
Chicago, IL – August 13, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Can Ferrari Maintain Pole Position After Its Q2 Performance?
Ferrari N.V. RACE has been firing on all cylinders, with second-quarter 2025 results underscoring why the prancing horse continues to outpace the broader auto sector. The luxury automaker’s revenues


